Literature DB >> 33507974

Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis.

Xiao-Bin Zhang1,2, Lan Hu3, Quan Ming4, Xiao-Jie Wei5, Zhen-Yu Zhang6, Li-Da Chen7, Ming-Hui Wang1,2, Weng-Zhen Yao1,2, Qiu-Fen Huang1,2, Zhang-Qiang Ye1,2, Yu-Qing Cai1,2, Hui-Qing Zeng1,2.   

Abstract

PURPOSE: Since the outbreak in late December 2019 in Wuhan, China, coronavirus disease-2019 (COVID-19) has become a global pandemic. We analyzed and compared the clinical, laboratory, and radiological characteristics between survivors and non-survivors and identify risk factors for mortality.
METHODS: Clinical and laboratory variables, radiological features, treatment approach, and complications were retrospectively collected in two centers of Hubei province, China. Cox regression analysis was conducted to identify the risk factors for mortality.
RESULTS: A total of 432 patients were enrolled, and the median patient age was 54 years. The overall mortality rate was 5.09% (22/432). As compared with the survivor group (n = 410), those in the non-survivor group (n = 22) were older, and they had a higher frequency of comorbidities and were more prone to suffer from dyspnea. Several abnormal laboratory variables indicated that acute cardiac injury, hepatic damage, and acute renal insufficiency were detected in the non-survivor group. Non-surviving patients also had a high computed tomography (CT) score and higher rate of consolidation. The most common complication causing death was acute respiratory distress syndrome (ARDS) (18/22, 81.8%). Multivariate Cox regression analysis revealed that hemoglobin (Hb) <90 g/L (hazard ratio, 10.776; 95% confidence interval, 3.075-37.766; p<0.0001), creatine kinase (CK-MB) >8 U/L (9.155; 2.424-34.584; p = 0.001), lactate dehydrogenase (LDH) >245 U/L (5.963; 2.029-17.529; p = 0.001), procalcitonin (PCT) >0.5 ng/ml (7.080; 1.671-29.992; p = 0.008), and CT score >10 (39.503; 12.430-125.539; p<0.0001) were independent risk factors for the mortality of COVID-19.
CONCLUSIONS: Low Hb, high LDH, PCT, and CT score on admission were the predictors for mortality and could assist clinicians in early identification of poor prognosis among COVID-19 patients.

Entities:  

Year:  2021        PMID: 33507974      PMCID: PMC7842894          DOI: 10.1371/journal.pone.0246030

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  23 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

3.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  COVID-19 with Different Severities: A Multicenter Study of Clinical Features.

Authors:  Yun Feng; Yun Ling; Tao Bai; Yusang Xie; Jie Huang; Jian Li; Weining Xiong; Dexiang Yang; Rong Chen; Fangying Lu; Yunfei Lu; Xuhui Liu; Yuqing Chen; Xin Li; Yong Li; Hanssa Dwarka Summah; Huihuang Lin; Jiayang Yan; Min Zhou; Hongzhou Lu; Jieming Qu
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

6.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440

7.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

8.  Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.

Authors:  Guqin Zhang; Chang Hu; Linjie Luo; Fang Fang; Yongfeng Chen; Jianguo Li; Zhiyong Peng; Huaqin Pan
Journal:  J Clin Virol       Date:  2020-04-09       Impact factor: 3.168

9.  SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.

Authors:  G Y Oudit; Z Kassiri; C Jiang; P P Liu; S M Poutanen; J M Penninger; J Butany
Journal:  Eur J Clin Invest       Date:  2009-05-06       Impact factor: 4.686

10.  Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis.

Authors:  Xinhui Wang; Xuexian Fang; Zhaoxian Cai; Xiaotian Wu; Xiaotong Gao; Junxia Min; Fudi Wang
Journal:  Research (Wash D C)       Date:  2020-04-19
View more
  15 in total

1.  Cardiac biomarkers and COVID-19: A systematic review and meta-analysis.

Authors:  Wen An; Ju-Seop Kang; Qiuyang Wang; Tae-Eun Kim
Journal:  J Infect Public Health       Date:  2021-07-29       Impact factor: 7.537

Review 2.  COVID-19 and corticosteroids: a narrative review.

Authors:  Gaber El-Saber Batiha; Ali I Al-Gareeb; Hebatallah M Saad; Hayder M Al-Kuraishy
Journal:  Inflammopharmacology       Date:  2022-05-13       Impact factor: 5.093

3.  Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia.

Authors:  David Rene Rodriguez Lima; Ángela María Pinzón Rondón; Cristhian Rubio Ramos; Darío Isaías Pinilla Rojas; Maria José Niño Orrego; Mateo Andrés Díaz Quiroz; Nicolás Molano-González; Jorge Enrique Ceballos Quintero; Alex Francisco Arroyo Santos; Ángela María Ruiz Sternberg
Journal:  Int J Emerg Med       Date:  2022-05-21

4.  Clinical features, laboratory characteristics and risk factors for mortality of COVID-19 patients in a secondary hospital in Oman during the first wave of the SARS-CoV-2 pandemic.

Authors:  Zayid K Almayahi; A V Raveendran; Rashid Al Malki; Amira Safwat; Muradjan Al Baloshi; Amal Abbas; Ahmed S Al Salami; Sami M Al Mujaini; Khalid Al Dhuhli; Said Al Mandhari
Journal:  Bull Natl Res Cent       Date:  2022-05-16

5.  Clinical features predicting COVID-19 mortality risk.

Authors:  Hamidreza Kouhpayeh
Journal:  Eur J Transl Myol       Date:  2022-04-12

Review 6.  Therapeutic potential of induced iron depletion using iron chelators in Covid-19.

Authors:  Punnoth Poonkuzhi Naseef; Muhammed Elayadeth-Meethal; K T Mohammed Salim; A Anjana; C Muhas; K Abdul Vajid; Mohamed Saheer Kuruniyan
Journal:  Saudi J Biol Sci       Date:  2021-12-13       Impact factor: 4.052

7.  Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia.

Authors:  Kseniya Rubina; Anna Shmakova; Aslan Shabanov; Yulii Andreev; Natalia Borovkova; Vladimir Kulabukhov; Anatoliy Evseev; Konstantin Popugaev; Sergey Petrikov; Ekaterina Semina
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

8.  Breakdown of Diabetic Foot Ulcer Care during the First Year of the Pandemic in Poland: A Retrospective National Cohort Study.

Authors:  Marcin Kleibert; Beata Mrozikiewicz-Rakowska; Patrycja Małgorzata Bąk; Daniel Bałut; Jakub Zieliński; Leszek Czupryniak
Journal:  Int J Environ Res Public Health       Date:  2022-03-23       Impact factor: 3.390

Review 9.  Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Alessandro G Fois; Arduino A Mangoni
Journal:  Adv Med Sci       Date:  2021-07-07       Impact factor: 3.287

10.  Clinical Characteristics of COVID-19 Patients' Postvaccination.

Authors:  Xiao-Bin Zhang; Si-Jiu Yang; Yong Lin; Li-Li Chen; Ya-Li Zhuang; Hui-Qing Zeng
Journal:  Viral Immunol       Date:  2022-03-24       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.